Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:11:23.177Z.
Calculation as of: 2026-10-06T14:11:23.177Z.
Quote observation: 2026-10-06T14:10:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f12fe6f09ebba39ad61e3a87243b01e46bba3d7bd48a90cbad4cda1dbeff8bd9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$47.47M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.95M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.31M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.28M
Operating Cash Flow Yield
48.46%
TTM Avg
50.32%
3Y Avg
31.17%
5Y Avg
36.60%
Market Cap
$52.41M
Operating Cash Flow Yield
N/A
TTM Avg
10.62%
3Y Avg
10.36%
5Y Avg
10.36%
Market Cap
$45.18M
Operating Cash Flow Yield
N/A
TTM Avg
11.87%
3Y Avg
9.02%
5Y Avg
6.85%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clene Inc. (CLNN) | $48.94M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $48.20M | N/A | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.47M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.95M | N/A | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.31M | N/A | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $55.97M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $50.28M | 48.46% | 50.32% | 31.17% | 36.60% |
| Microbot Medical Inc. (MBOT)vs › | $52.41M | N/A | 10.62% | 10.36% | 10.36% |
| BioStem Technologies, Inc. (BSEM)vs › | $45.18M | N/A | 11.87% | 9.02% | 6.85% |
| DarioHealth Corp. (DRIO)vs › | $45.37M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
